Works matching AU Tani, Joji

Results: 161
    1
    2

    Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

    Published in:
    Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192
    By:
    • Hatanaka, Takeshi;
    • Yata, Yutaka;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Kakizaki, Satoru;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Koshiyama, Yuichi;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi
    Publication type:
    Article
    3
    4

    Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis.

    Published in:
    Oncology, 2025, v. 103, n. 2, p. 94, doi. 10.1159/000541002
    By:
    • Hatanaka, Takeshi;
    • Saito, Naoto;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Ishikawa, Toru;
    • Toyoda, Hidenori;
    • Kawata, Kazuhito;
    • Naganuma, Atsushi;
    • Yata, Yutaka;
    • Ohama, Hideko;
    • Matono, Tomomitsu;
    • Tada, Fujimasa;
    • Nouso, Kazuhiro;
    • Morishita, Asahiro;
    • Tsutsui, Akemi
    Publication type:
    Article
    5

    Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

    Published in:
    Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    6

    Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

    Published in:
    Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    7

    Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

    Published in:
    Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Hirooka, Masashi;
    • Takaguchi, Koichi;
    • Atsukawa, Masanori;
    • Fukunishi, Shinya;
    • Itobayashi, Ei;
    • Tsuji, Kunihiko;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Ishikawa, Toru;
    • Yasuda, Satoshi;
    • Ogawa, Chikara;
    • Toyoda, Hidenori;
    • Hatanaka, Takeshi;
    • Nishimura, Takashi;
    • Kakizaki, Satoru
    Publication type:
    Article
    8

    Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    9

    Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study.

    Published in:
    Oncology, 2017, v. 93, p. 113, doi. 10.1159/000481241
    By:
    • Ogawa, Chikara;
    • Morita, Masahiro;
    • Omura, akina;
    • Noda, Teruyo;
    • Kubo, atsushi;
    • Matsunaka, Toshihiro;
    • Tamaki, Hiroyuki;
    • Shibatoge, Mitsushige;
    • Tsutsui, akemi;
    • Senoh, Tomonori;
    • Nagano, Takuya;
    • Takaguchi, Kouichi;
    • Tani, Joji;
    • Morishita, asahiro;
    • Yoneyama, Hirohito;
    • Masaki, Tsutomu;
    • Moriya, akio;
    • ando, Masaharu;
    • Deguchi, akihiro;
    • Kokudo, Yasutaka
    Publication type:
    Article
    10

    Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.

    Published in:
    Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74
    By:
    • Nouso, Kazuhiro;
    • Shiota, Shohei;
    • Fujita, Rio;
    • Wakuta, Akiko;
    • Kariyama, Kazuya;
    • Hiraoka, Atsushi;
    • Atsukawa, Masanori;
    • Tani, Joji;
    • Tada, Toshifumi;
    • Matsuo, Yu;
    • Nakamura, Shinichiro;
    • Tajiri, Kazuto;
    • Kaibori, Masaki;
    • Hirooka, Masashi;
    • Itobayashi, Ei;
    • Kakizaki, Satoru;
    • Naganuma, Atsushi;
    • Ishikawa, Toru;
    • Hatanaka, Takeshi;
    • Fukunishi, Shinya
    Publication type:
    Article
    11

    Association Between Laboratory Values and Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Multicenter, Retrospective Study.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 6, p. 1858, doi. 10.3390/jcm14061858
    By:
    • Koyano, Kaori;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Miwa, Takao;
    • Namisaki, Tadashi;
    • Hiraoka, Atsushi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Kobayashi, Yuji;
    • Kawata, Kazuhito;
    • Matsuura, Kentaro;
    • Mikami, Shigeru;
    • Kawabe, Naoto;
    • Oikawa, Tsunekazu;
    • Suzuki, Kenta;
    • Kawano, Tadamichi;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Tani, Joji
    Publication type:
    Article
    12

    Effective and Secure Closure after Duodenal Endoscopic Submucosal Dissection: Combination of Endoscopic Ligation with O-Ring Closure and Over-the-Scope Clip.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4238, doi. 10.3390/jcm12134238
    By:
    • Nakatani, Kaho;
    • Kobara, Hideki;
    • Nishiyama, Noriko;
    • Fujihara, Shintaro;
    • Tada, Naoya;
    • Koduka, Kazuhiro;
    • Matsui, Takanori;
    • Chiyo, Taiga;
    • Kobayashi, Nobuya;
    • Yachida, Tatsuo;
    • Tani, Joji;
    • Morishita, Asahiro;
    • Isomoto, Hajime;
    • Masaki, Tsutomu
    Publication type:
    Article
    13

    Gastrointestinal Residue Removal Using a Balloon Overtube under Ultrathin Endoscopic Navigation: Ex Vivo and In Vivo Experimental Studies.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3796, doi. 10.3390/jcm10173796
    By:
    • Kozuka, Kazuhiro;
    • Kobara, Hideki;
    • Nishiyama, Noriko;
    • Fujihara, Shintaro;
    • Tada, Naoya;
    • Matsui, Takanori;
    • Takata, Tadayuki;
    • Chiyo, Taiga;
    • Kobayashi, Nobuya;
    • Shi, Tingting;
    • Fujita, Koji;
    • Tani, Joji;
    • Yachida, Tatsuo;
    • Kondo, Akihiro;
    • Kumamoto, Kensuke;
    • Okano, Keiichi;
    • Nishiyama, Akira;
    • Deguchi, Kazushi;
    • Masaki, Tsutomu
    Publication type:
    Article
    14
    15
    16

    Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    17

    What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
    By:
    • Atsushi Hiraoka;
    • Takashi Kumada;
    • Toshifumi Tada;
    • Kazuya Kariyama;
    • Joji Tani;
    • Shinya Fukunishi;
    • Masanori Atsukawa;
    • Masashi Hirooka;
    • Kunihiko Tsuji;
    • Toru Ishikawa;
    • Koichi Takaguchi;
    • Ei Itobayashi;
    • Kazuto Tajiri;
    • Noritomo Shimada;
    • Hiroshi Shibata;
    • Hironori Ochi;
    • Kazuhito Kawata;
    • Satoshi Yasuda;
    • Hidenori Toyoda;
    • Hideko Ohama
    Publication type:
    Article
    18

    Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction‐associated steatotic liver disease: A multicentre study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1498, doi. 10.1111/dom.16157
    By:
    • Fukunaga, Kensaku;
    • Morishita, Asahiro;
    • Imachi, Hitomi;
    • Oura, Kyoko;
    • Sato, Seisuke;
    • Kobayashi, Toshihiro;
    • Saheki, Takanobu;
    • Yoshimura, Takafumi;
    • Komori, Kurumi;
    • Nakahara, Mai;
    • Tadokoro, Tomoko;
    • Fujita, Koji;
    • Tani, Joji;
    • Kobara, Hideki;
    • Murao, Koji
    Publication type:
    Article
    19

    Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4958, doi. 10.1111/dom.15898
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Oikawa, Tsunekazu;
    • Tada, Toshifumi;
    • Matsuura, Kentaro;
    • Ishikawa, Toru;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Morishita, Asahiro;
    • Tani, Joji;
    • Okubo, Tomomi;
    • Nagao, Mototsugu;
    • Iwabu, Masato;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    20

    Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
    By:
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi;
    • Kawata, Kazuhito;
    • Kosaka, Hisashi
    Publication type:
    Article
    21

    Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Nishikawa, Hiroki;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Koshiyama, Yuichi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Kawata, Kazuhito
    Publication type:
    Article
    22

    Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.

    Published in:
    Molecular Medicine Reports, 2020, v. 22, n. 2, p. 1063, doi. 10.3892/mmr.2020.11144
    By:
    • Kobara, Hideki;
    • Fujihara, Shintaro;
    • Iwama, Hisakazu;
    • Matsui, Takanori;
    • Fujimori, Ayako;
    • Chiyo, Taiga;
    • Tingting, Shi;
    • Kobayashi, Nobuya;
    • Nishiyama, Noriko;
    • Yachida, Tatsuo;
    • Tadokoro, Tomoko;
    • Oura, Kyoko;
    • Tani, Joji;
    • Fujita, Koji;
    • Nomura, Takako;
    • Yoneyama, Hirohito;
    • Morishita, Asahiro;
    • Okano, Keiichi;
    • Suzuki, Yasuyuki;
    • Mori, Hirohito
    Publication type:
    Article
    23

    Galectin-9 ameliorates fulminant liver injury.

    Published in:
    Molecular Medicine Reports, 2017, v. 16, n. 1, p. 36, doi. 10.3892/mmr.2017.6606
    By:
    • Tomoko Tadokoro;
    • Asahiro Morishita;
    • Teppei Sakamoto;
    • Shintaro Fujihara;
    • Koji Fujita;
    • Shima Mimura;
    • Kyoko Oura;
    • Takako Nomura;
    • Joji Tani;
    • Hirohito Yoneyama;
    • Hisakazu Iwama;
    • Takashi Himoto;
    • Toshiro Niki;
    • Tsutomu Masaki
    Publication type:
    Article
    24
    25
    26

    Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.

    Published in:
    PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0261310
    By:
    • Morishita, Asahiro;
    • Tadokoro, Tomoko;
    • Fujihara, Shintaro;
    • Iwama, Hisakazu;
    • Oura, Kyoko;
    • Fujita, Koji;
    • Tani, Joji;
    • Takuma, Kei;
    • Nakahara, Mai;
    • Shi, Tingting;
    • Haba, Reiji;
    • Okano, Keiichi;
    • Nishiyama, Akira;
    • Ono, Masafumi;
    • Himoto, Takashi;
    • Masaki, Tsutomu
    Publication type:
    Article
    27

    Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo.

    Published in:
    Oncology Reports, 2021, v. 45, n. 6, p. N.PAG, doi. 10.3892/or.2021.8056
    By:
    • Morishita, Asahiro;
    • Nomura, Kei;
    • Tani, Joji;
    • Fujita, Koji;
    • Iwama, Hisakazu;
    • Takuma, Kei;
    • Nakahara, Mai;
    • Tadokoro, Tomoko;
    • Oura, Kyoko;
    • Chiyo, Taiga;
    • Fujihara, Shintaro;
    • Niki, Toshiro;
    • Hirashima, Mitsuomi;
    • Nishiyama, Akira;
    • Himoto, Takashi;
    • Masaki, Tsutomu
    Publication type:
    Article
    28
    29
    30

    Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    31
    32

    Outcomes of Endoscopic Submucosal Dissection for Subepithelial Lesions Localized Within the Submucosa, Including Neuroendocrine Tumors: A Multicenter Prospective Study.

    Published in:
    Journal of Gastrointestinal & Liver Diseases, 2020, v. 29, n. 1, p. 41, doi. 10.15403/jgld-510
    By:
    • Hideki Kobara;
    • Yoichi Miyaoka;
    • Yoshio Ikeda;
    • Takayoshi Yamada;
    • Masashi Takata;
    • Shintaro Fujihara;
    • Noriko Nishiyama;
    • Koji Fujita;
    • Joji Tani;
    • Nobuya Kobayashi;
    • Taiga Chiyo;
    • Tatsuo Yachida;
    • Keiichi Okano;
    • Yasuyuki Suzuki;
    • Hirohito Mori;
    • Tsutomu Masaki
    Publication type:
    Article
    33

    Endoscopic Submucosal Dissection for Neoplasia of the Greater Curvature of the Upper and Middle Stomach: J-shaped Superficial Cutting and Splashed Dissection.

    Published in:
    Journal of Gastrointestinal & Liver Diseases, 2019, v. 28, n. 4, p. 397, doi. 10.15403/jgld-274
    By:
    • Noriko Nishiyama;
    • Hideki Kobara;
    • Shintaro Fujihara;
    • Kazuhiro Koduka;
    • Taiga Chiyo;
    • Nobuya Kobayashi;
    • Kouji Fujita;
    • Maki Ayaki;
    • Tatsuo Yachida;
    • Joji Tani;
    • Tingting Shi;
    • Keiichi Okano;
    • Yasuyuki Suzuki;
    • Hirohito Mori;
    • Tsutomu Masaki
    Publication type:
    Article
    34
    35
    36

    Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

    Published in:
    Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563
    By:
    • Toyoda, Hidenori;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Michitaka, Kojiro;
    • Takaguchi, Koichi;
    • Tsuji, Kunihiko;
    • Itobayashi, Ei;
    • Takizawa, Daichi;
    • Hirooka, Masashi;
    • Koizumi, Yohei;
    • Ochi, Hironori;
    • Joko, Koji;
    • Kisaka, Yoshiyasu;
    • Shimizu, Yuko;
    • Tajiri, Kazuto;
    • Tani, Joji;
    • Taniguchi, Tatsuya;
    • Toshimori, Akiko;
    • Fujioka, Shinichi;
    • Kumada, Takashi
    Publication type:
    Article
    37
    38
    39
    40
    41

    Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B.

    Published in:
    JGH Open, 2021, v. 5, n. 1, p. 34, doi. 10.1002/jgh3.12443
    By:
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Takaguchi, Koichi;
    • Nakamuta, Makoto;
    • Hiraoka, Atsushi;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Mikami, Shigeru;
    • Shimada, Noritomo;
    • Chuma, Makoto;
    • Akito, Nozaki;
    • Uojima, Haruki;
    • Ogawa, Chikara;
    • Asano, Toru;
    • Tani, Joji;
    • Morishita, Asahiro;
    • Senoh, Tomonori;
    • Yamashita, Naoki;
    • Oikawa, Tsunekazu
    Publication type:
    Article
    42

    Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study.

    Published in:
    International Journal of Oncology, 2017, v. 51, n. 2, p. 607, doi. 10.3892/ijo.2017.4053
    By:
    • TOMOKO TADOKORO;
    • SHINTARO FUJIHARA;
    • TAIGA CHIYO;
    • KYOKO OURA;
    • ERI SAMUKAWA;
    • YOSHIMI YAMANA;
    • KOJI FUJITA;
    • SHIMA MIMURA;
    • TEPPEI SAKAMOTO;
    • TAKAKO NOMURA;
    • JOJI TANI;
    • HIROHITO YONEYAMA;
    • ASAHIRO MORISHITA;
    • TAKASHI HIMOTO;
    • HISAKAZU IWAMA;
    • TOSHIRO NIKI;
    • MITSUOMI HIRASHIMA;
    • TSUTOMU MASAKI
    Publication type:
    Article
    43

    Galectin-9: An anticancer molecule for gallbladder carcinoma.

    Published in:
    International Journal of Oncology, 2016, v. 48, n. 3, p. 1165, doi. 10.3892/ijo.2016.3347
    By:
    • TOMOKO TADOKORO;
    • ASAHIRO MORISHITA;
    • SHINTARO FUJIHARA;
    • HISAKAZU IWAMA;
    • TOSHIRO NIKI;
    • KOJI FUJITA;
    • EMIKO AKASHI;
    • SHIMA MIMURA;
    • KYOKO OURA;
    • TEPPEI SAKAMOTO;
    • TAKAKO NOMURA;
    • JOJI TANI;
    • HISAAKI MIYOSHI;
    • HIROHITO YONEYAMA;
    • TAKASHI HIMOTO;
    • MITSUOMI HIRASHIMA;
    • TSUTOMU MASAKI
    Publication type:
    Article
    44

    Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth.

    Published in:
    International Journal of Oncology, 2015, v. 47, n. 4, p. 1293, doi. 10.3892/ijo.2015.3118
    By:
    • YUKA TOYOTA;
    • HISAKAZU IWAMA;
    • KIYOHITO KATO;
    • JOJI TANI;
    • AKIKO KATSURA;
    • MIWA MIYATA;
    • SHINTARO FUJIWARA;
    • KOJI FUJITA;
    • TEPPEI SAKAMOTO;
    • TAKAYUKI FUJIMORI;
    • RYOICHI OKURA;
    • KIYOYUKI KOBAYASHI;
    • TOMOKO TADOKORO;
    • SHIMA MIMURA;
    • TAKAKO NOMURA;
    • HISAAKI MIYOSHI;
    • ASAHIRO MORISHITA;
    • HIDEKI KAMADA;
    • HIROHITO YONEYAMA;
    • KEIICHI OKANO
    Publication type:
    Article
    45

    MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.

    Published in:
    International Journal of Oncology, 2015, v. 47, n. 2, p. 535, doi. 10.3892/ijo.2015.3036
    By:
    • MIWA MIYATA;
    • ASAHIRO MORISHITA;
    • TEPPEI SAKAMOTO;
    • AKIKO KATSURA;
    • KIYOHITO KATO;
    • TOMOKO NISHIOKA;
    • YUKA TOYOTA;
    • KOJI FUJITA;
    • EMIKO MAEDA;
    • TAKAKO NOMURA;
    • JOJI TANI;
    • HISAAKI MIYOSHI;
    • HIROHITO YONEYAMA;
    • HIDEKI KOBARA;
    • SHINTARO FUJIWARA;
    • NORIKO NISHIYAMA;
    • HISAKAZU IWAMA;
    • TAKASHI HIMOTO;
    • MITSUOMI HIRASHIMA;
    • TSUTOMU MASAKI
    Publication type:
    Article
    46

    Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.

    Published in:
    International Journal of Oncology, 2015, v. 46, n. 6, p. 2419, doi. 10.3892/ijo.2015.2941
    By:
    • FUJITA, KOJI;
    • IWAMA, HISAKAZU;
    • SAKAMOTO, TEPPEI;
    • OKURA, RYOICHI;
    • KOBAYASHI, KIYOYUKI;
    • TAKANO, JITSUKO;
    • KATSURA, AKIKO;
    • TATSUTA, MIWA;
    • MAEDA, EMIKO;
    • MIMURA, SHIMA;
    • NOMURA, TAKAKO;
    • TANI, JOJI;
    • MIYOSHI, HISAAKI;
    • MORISHITA, ASAHIRO;
    • YONEYAMA, HIROHITO;
    • YAMANA, YUKA;
    • HIMOTO, TAKASHI;
    • OKANO, KEIICHI;
    • SUZUKI, YASUYUKI;
    • NIKI, TOSHIRO
    Publication type:
    Article
    47

    Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.

    Published in:
    International Journal of Oncology, 2014, v. 45, n. 1, p. 322, doi. 10.3892/ijo.2014.2419
    By:
    • HISAAKI MIYOSHI;
    • KIYOHITO KATO;
    • HISAKAZU IWAMA;
    • EMIKO MAEDA;
    • TEPPEI SAKAMOTO;
    • KOJI FUJITA;
    • YUKA TOYOTA;
    • JOJI TANI;
    • TAKAKO NOMURA;
    • SHIMA MIMURA;
    • MITSUYOSHI KOBAYASHI;
    • ASAHIRO MORISHITA;
    • HIDEKI KOBARA;
    • HIROHITO MORI;
    • HIROHITO YONEYAMA;
    • AKIHIRO DEGUCHI;
    • TAKASHI HIMOTO;
    • KAZUTAKA KUROKOHCHI;
    • KEIICHI OKANO;
    • YASUYUKI SUZUKI
    Publication type:
    Article
    48
    49
    50

    MicroRNAs and Nonalcoholic Steatohepatitis: A Review.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14482, doi. 10.3390/ijms241914482
    By:
    • Morishita, Asahiro;
    • Oura, Kyoko;
    • Tadokoro, Tomoko;
    • Fujita, Koji;
    • Tani, Joji;
    • Kobara, Hideki;
    • Ono, Masafumi;
    • Himoto, Takashi;
    • Masaki, Tsutomu
    Publication type:
    Article